🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#ICYMI: UC Davis Comprehensive Cancer Cent oncologist Dr. Mamta Parikh discusses some exciting new therapies in the treatment of prostate cancer on the latest episode of the Beat Cancer podcast. spr.ly/6011PNSs5 #prostate #podcast UC Davis Health

We're proud to be the home of CA’s first center committed to helping people quit #smoking and identifying policy solutions to curb #tobacco addiction and keep youth from using tobacco products. ucdavis.health/3EWOy1W UC Davis Health ACS CAN California @Calquits UCOP Newsroom UCLA Health

The 29th Annual Cancer Research Symposium UC Davis Comprehensive Cancer Cent is under way! Lucky Lara gives the opening address with keynotes and poster presentations to follow. UC Davis Health UC Davis Research

The SWOG Cancer Research Network fall 2023 group meeting opens on Wednesday, Oct 11, in Chicago and online! Get the meeting app to light your way as you navigate 80+ sessions. swog.org/news-events/sw… #SWOGonc #NCTN #NCORP

Just In Kidney Cancer👉Remarkable Review by James Brundage Benjamin L Maughan on the efficacy of MET inhibitors in pts with papillary RCC 👉tinyurl.com/44dkmddz 👉Cabozantinib has the best evidence for use as 1L Rx OncoAlert Kidney Cancer UroToday.com

Recently In Kidney Cancer 👉Excellent Review by Nicholas Schindler David Braun on tumor antigen targets in ccRCC👉tinyurl.com/3wvym7se👉A concerted effort for antigen discovery is needed to design future precision antigen-directed IO OncoAlert Kidney Cancer UroToday.com

Now through Oct 31, stop by your favorite Panera Bread location and when you round up your purchase, you directly support UC Davis Comprehensive Cancer Cent. So whether you're going for coffee and bagels or a hearty dinner, don't forget to #roundup!

The 2023 AACI/CCAF Annual Meeting spanned a range of topics, from community outreach to global oncology. AACI Annual Meeting Program Committee Chair Lucky Lara shares his perspective on the meeting in the October 2023 #AACICommentary. conta.cc/3txmPCO #AACI2023

Read the Association of American Cancer Institutes Oct 2023 Commentary from UC Davis Comprehensive Cancer Cent's Director Lucky Lara: "From Community Outreach to Global Oncology: Perspectives on the 2023 AACI/CCAF Annual Meeting" ucdavis.health/46SAFOw UC Davis Health

Now through Oct 31, stop by your favorite Panera Bread location and when you round up your purchase, you directly support UC Davis Comprehensive Cancer Cent. So whether you're going for coffee and bagels or a hearty dinner, don't forget to #roundup!

Positive results of RENOTORCH trial of the anti PD1 Toripalimab + Axitinib vs Sunitinib favoring the combination was presented by Dr X Zheng @ESMO. While PFS was significant, I consider this a “lateral pass” (making a football analogy), and not a forward pass in the current era

Now through Oct 31, stop by your favorite Panera Bread location and when you round up your purchase, you directly support UC Davis Comprehensive Cancer Cent. So whether you're going for coffee and bagels or a hearty dinner, don't forget to #roundup!

Congrats to Dr. Elisa Tong on being named assistant director for population sciences UC Davis Comprehensive Cancer Cent. Dr. Tong is a renowned tobacco researcher and will focus on health equity to improve cancer prevention, screening, treatment, & survivorship. ucdavis.health/3QWfrJ8 UC Davis Health

Bravo to @mitsiades and team UC Davis Comprehensive Cancer Cent on this forward thinking approach to maximizing the potential of liquid biopsy , from monitoring first cancer to diagnosis of a 2nd cancer. Lucky Lara

Groundbreaking research by UC Davis Health scientists and co-researchers points to a way to detonate the 'doors' that lead to the heart of cancerous tumors in #patients, making this area wide open for effective drug treatments. ucdavis.health/3QSjJ4a

Just in Kidney Cancer 👉Excellent systematic review by Eric Jonasch on different Rx modalities for VHL-associated RCC #kidneycancer 👉Responses were observed w/ systemic Rx, including belzutifan, warranting additional studies👉tinyurl.com/5xh9w9bc OncoAlert UroToday.com KidneyCAN

Our C Blanke, SWOG Chair blog: Data Capture with nCartes: A Leap Day Opportunity In our SWOG Cancer Research Network-nCartes system, data from the electronic health record are automatically fed to the software, reviewed by study coordinators, then passed directly to case report forms. swog.org/news-events/ne…

Just in Kidney Cancer 👉Excellent review by #AlbertLee James Yu on the role of radiation therapy (SBRT) in the Rx of localized and oligometastatic RCC #kidneycancer👉SBRT use will likely increase in the future 👇👇 tinyurl.com/y3upcu8m UroToday.com OncoAlert KidneyCAN

Just in 👉data from SWOG Cancer Research Network 1216 trial in mHSPC#prostatecancer👉 PSA level at 3 and 7 months after starting ADT Rx are strongly prognostic of OS: It’s time to design de- or escalation trials based on response biomarkers. OPEN access👉 tinyurl.com/3azhpt4r OncoAlert UroToday.com

Our C Blanke, SWOG Chair blog: More Results: SWOG Trials That Keep on Giving To keep SWOG Cancer Research Network members informed of our research results, I'm highlighting important findings presented at two recent meetings, in #prostate cancer and rare #sarcomatoid carcinoma lung tumors swog.org/news-events/ne…